{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:20:47Z","timestamp":1792646447721,"version":"4.5.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700073"],"award-info":[{"award-number":["81700073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is a predominantly respiratory infectious disease caused by novel coronavirus infection (SARS-CoV-2), respiratory failure is the main clinical manifestation and the leading cause of death. Even though it can meet the acute respiratory distress syndrome (ARDS) Berlin definition, only some clinical features of COVID-19 are consistent with typical ARDS, and which has its own peculiar phenotypes. When compared with typical ARDS, in addition to the typical diffuse alveolar injury, COVID-19 has unique pathological and pathophysiological features, such as endothelial injury, extensive microthrombus, and pulmonary capillary hyperplasia. The clinical features of patients with respiratory failure caused by COVID-19 are heterogeneous and can be generally divided into two phenotypes: progressive respiratory distress and unique \u201csilent hypoxemia\u201d. The \u201cH-type\u201d characteristics of reduced lung volume, decreased lung compliance, and unmatched ventilator-perfusion ratio. While some patients may have close to normal lung compliance, that is \u201cL-type\u201d. Identifying the exact phenotype in whom are suffered with COVID-19 is crucial to guide clinicians to adopt appropriate treatment strategies. This review discussed the similarities and differences in the pathogenesis, pathophysiology, clinical features and treatment strategies of COVID-19 induced acute respiratory failure and typical ARDS.<\/jats:p>","DOI":"10.3389\/fmed.2022.829771","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:30:58Z","timestamp":1654065058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences"],"prefix":"10.3389","volume":"9","author":[{"given":"Sen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/CM9.0000000000000819","volume":"133","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/ALN.0000000000003578","article-title":"\u201cSilent\u201d Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19","volume":"134","author":"Bickler","year":"2021","journal-title":"Anesthesiology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-020-02880-z","article-title":"COVID-19 pneumonia: ARDS or not?","volume":"24","author":"Gattinoni","year":"2020","journal-title":"Crit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1165\/rcmb.F305","article-title":"Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management","volume":"33","author":"Matthay","year":"2005","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B11","first-page":"209","article-title":"Diffuse alveolar damage\u2013the role of oxygen, shock, and related factors","volume":"85","author":"Katzenstein","year":"1976","journal-title":"A review Am J Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. a first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"103455","DOI":"10.1016\/j.resp.2020.103455","article-title":"Distinct phenotypes require distinct respiratory management strategies in severe COVID-19","volume":"279","author":"Robba","year":"2020","journal-title":"Respir Physiol Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/L20-1206","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00134-005-2627-z","article-title":"The concept of \u201cbaby lung\u201d","volume":"31","author":"Gattinoni","year":"2005","journal-title":"Intensive Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1001\/jama.255.18.2463","article-title":"Preservation of normal lung regions in the adult respiratory distress syndrome. Analysis by computed tomography","volume":"255","author":"Maunder","year":"1986","journal-title":"JAMA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1164\/rccm.201610-2156SO","article-title":"Fifty Years of Research in ARDS. Gas exchange in acute respiratory distress syndrome","volume":"196","author":"Radermacher","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-0039-1685159","article-title":"Acute respiratory distress syndrome: respiratory monitoring and pulmonary physiology","volume":"40","author":"Coudroy","year":"2019","journal-title":"Semin Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJM197012242832603","article-title":"Continuous positive-pressure ventilation in acute respiratory failure","volume":"283","author":"Kumar","year":"1970","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00134-015-4141-2","article-title":"Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact","volume":"42","author":"Mekontso Dessap","year":"2016","journal-title":"Intensive Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1378\/chest.90.1.74","article-title":"Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS","volume":"90","author":"Dhainaut","year":"1986","journal-title":"Chest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1001\/jama.2020.6825","article-title":"Management of COVID-19 respiratory distress","volume":"323","author":"Marini","year":"2020","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e200067","DOI":"10.1148\/ryct.2020200067","article-title":"COVID-19 Complicated by acute pulmonary embolism","volume":"2","author":"Xie","year":"2020","journal-title":"Radiol Cardiothorac Imaging."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study","volume":"8","author":"Grasselli","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1164\/rccm.201709-1804OC","article-title":"Reclassifying acute respiratory distress syndrome","volume":"197","author":"Maiolo","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1164\/rccm.201605-1081CP","article-title":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure","volume":"195","author":"Brochard","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MCC.0000000000000691","article-title":"Patient self-inflicted lung injury and positive end-expiratory pressure for safe spontaneous breathing","volume":"26","author":"Yoshida","year":"2020","journal-title":"Curr Opin Crit Care."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of Coronavirus disease 2019 in China","volume":"382","author":"Guan WJ Ni","year":"2020","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 Silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3760\/cma.j.cn121430-20210126-00121","volume":"33","author":"Yang","year":"2021","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u201ccytokine storm\u201d in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B38","article-title":"COVID-19 versus non-COVID ARDS: comparison of demographics, physiologic parameters, inflammatory biomarkers and clinical outcomes","volume-title":"Ann Am Thorac Soc","author":"Bain","year":"2020"},{"key":"B39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13613-019-0540-9","article-title":"Formal guidelines: management of acute respiratory distress syndrome","volume":"9","author":"Papazian","year":"2019","journal-title":"Ann Intensive Care."},{"key":"B40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: is it \u201ctypical\u201d ARDS?","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000004899","article-title":"Surviving sepsis campaign guidelines on the management of adults with Coronavirus disease 2019 (COVID-19) in the ICU: first update","volume":"49","author":"Alhazzani","year":"2021","journal-title":"Crit Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"17534666211009407","DOI":"10.1177\/17534666211009407","article-title":"The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis","volume":"15","author":"Tan","year":"2021","journal-title":"Ther Adv Respir Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2147\/JMDH.S279031","article-title":"Global current practices of ventilatory support management in COVID-19 Patients: an international survey","volume":"13","author":"Alqahtani","year":"2020","journal-title":"J Multidiscip Healthc."},{"key":"B44","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S2213-2600(20)30268-X","article-title":"Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study","volume":"8","author":"Coppo","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13543784.2020.1699531","article-title":"Personalized pharmacological therapy for ARDS: a light at the end of the tunnel","volume":"29","author":"Silva","year":"2020","journal-title":"Expert Opin Investig Drugs."},{"key":"B46","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B."},{"key":"B48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.arcmed.2020.09.010","article-title":"Coronavirus Disease (COVID-19): Current status and prospects for drug and vaccine development","volume":"52","author":"Ita","year":"2021","journal-title":"Arch Med Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","article-title":"COVID-19: Discovery, diagnostics and drug development","volume":"74","author":"Asselah","year":"2021","journal-title":"J Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"105778","DOI":"10.1016\/j.actatropica.2020.105778","article-title":"One year update on the COVID-19 pandemic: Where are we now?","volume":"214","author":"Mishra","year":"2021","journal-title":"Acta Trop."},{"key":"B51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/bmj.o80","volume":"377","author":"Update","year":"2022","journal-title":"BMJ."},{"key":"B58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","volume":"326","author":"Munch","year":"2021","journal-title":"JAMA."},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.3390\/ph12010037","article-title":"Baricitinib: A 2018 novel FDA-approved small molecule inhibiting janus kinases","volume-title":"Pharmaceuticals (Basel)","author":"Mayence","year":"2019"},{"key":"B62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"n860","DOI":"10.1136\/bmj.n860","volume":"372","author":"Update","year":"2021","journal-title":"BMJ."},{"key":"B65","doi-asserted-by":"publisher","first-page":"CD013881","DOI":"10.1002\/14651858.CD013881","article-title":"Interleukin-6 blocking agents for treating COVID-19: a living systematic review","volume":"3","author":"Ghosn","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"JAMA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11239-020-02242-0","article-title":"Anticoagulant treatment in COVID-19: a narrative review","volume":"51","author":"Carfora","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur Heart J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.829771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:31:03Z","timestamp":1654065063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.829771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":71,"alternative-id":["10.3389\/fmed.2022.829771"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.829771","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"829771"}}